AU-006

• Description :

  AU-006 is an orally active inhibitor of gastric acid secretion, with anti-ulcer effects. AU-006 does not rely on NO and mucus regulation. AU-006 significantly prevents 95% of gastric mucosal damage caused by ethanol and has broad-spectrum protective effects against chemical corrosive damage. AU-006 can be used for research on gastric ulcers[1]..

• UNSPSC :

  12352005

• Target :

  Endogenous Metabolite

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Endocrinology; Inflammation/Immunology

• Smiles :

  FC(F)(F)OC1=CC=CC2=C1N=C(NCCCO)C3=C2N(C4=C(C)C=CC=C4)CC3

• Molecular Formula :

  C22H22F3N3O2

• Molecular Weight :

  417.42

• References & Citations :

  [1]Cheon HG, et al. Pharmacological studies on the new quinoline derivative 1- (2-methylphenyl) -4-[ (3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect. Arzneimittelforschung. 1998 Dec;48 (12) :1168-71. PMID: 9893932.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [220831-12-9]